Results 181 to 190 of about 72,150 (302)

Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High‐Dose Cytarabine‐Based Chemotherapy as Second‐Line Treatments for Relapsed or Refractory Diffuse Large B‐Cell Lymphoma

Hematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT The optimal second‐line chemotherapy regimen for relapsed or refractory diffuse large B‐cell lymphoma (R/R DLBCL) remains uncertain. We retrospectively compared efficacy and safety between gemcitabine, carboplatin, dexamethasone, and rituximab (GCD‐R) and cyclophosphamide, high‐dose cytarabine, dexamethasone, etoposide, and rituximab (CHASER ...
Yoshikazu Ikoma, Nobuhiko Nakamura, Junichi Kitagawa, Naoki Hayase, Eri Takada, Takuro Matsumoto, Yuhei Shibata, Hiroshi Nakamura, Kei Fujita, Shin Lee, Tetsuji Morishita, Nobuhiro Kanemura, Senji Kasahara, Hideko Goto, Kenji Fukuno, Takeshi Hara, Michio Sawada, Hisashi Tsurumi, Masahito Shimizu   +18 more
wiley   +1 more source

An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment [PDF]

, 2014
John D. Gibbins, Lindsay R. Ancelet, Robert Weinkove, Benjamin J. Compton, Gavin F. Painter, Troels R. Petersen, Ian F. Hermans   +6 more
openalex   +1 more source

Myelodysplastic/Myeloproliferative Neoplasm in a Dog: A Case Report

Veterinary Medicine and Science, Volume 12, Issue 1, January 2026.
This is a bone marrow aspirate smear image from an 18‐year‐old mixed‐breed dog diagnosed with myelodysplastic/myeloproliferative neoplasm. Both peripheral blood and bone marrow examinations revealed marked myeloid hyperplasia and dysplastic changes. ABSTRACT Myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) is a clonal myeloid disorder ...
Sumin Cha, DoHyeon Yu, Hyeona Bae
wiley   +1 more source

Adult Acute Myeloid Leukaemia With <i>DDX3X::MLLT10</i>: A Rare Entity With Significant Unmet Clinical Needs. [PDF]

EJHaem
Ng JY, Sr A, Joshi M, Talaulikar D.
europepmc   +1 more source

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001 [PDF]

, 2017
Uy, Geoffrey L., Westervelt, Peter
core   +1 more source

Cytarabine Monotherapy as Bridging Treatment for Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia

, 2012
Woo Suck Suh, Mun Sung Cho, Jae Wook Lee, Pil Sang Jang, Nack Gyun Chung, Dae Chul Jeong, Bin Cho, Hack Ki Kim   +7 more
openalex   +1 more source

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma

, 2010
Nicola Gökbuget, Christine-Maria Hartog, Renato Bassan, Hans Guenter Derigs, Hervé Dombret, R. Greil, Jesús María Hernández‐Rivas, F. Huguet, Tamara Intermesoli, Éric Jourdan, Christian Junghanß, Lothar Leimer, M.-J. Moreno, Albrecht Reichle, Josep‐María Ribera, Mathias Schmid, Hubert Serve, M. Stelljes, Reingard Stuhlmann, D. Hoelzer   +19 more
openalex   +2 more sources

Data from Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells

, 2023
Xiaojia Niu, Jianyun Zhao, Jun Ma, Chengzhi Xie, Holly Edwards, Guan Wang, J. Timothy Caldwell, Shengyan Xiang, Xiaohong Zhang, Roland Chu, Zhihong J. Wang, Hai Lin, Jeffrey W. Taub, Yubin Ge   +13 more
openalex   +1 more source

A critical review of management of allogeneic transplant‐eligible adults with Ph+ acute lymphoblastic leukaemia

British Journal of Haematology, Volume 208, Issue 1, Page 39-53, January 2026.
Proposed management of newly diagnosed Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukaemia (ALL) in transplant‐eligible patients. Suggested considerations when deciding the treatment pathway available to a newly diagnosed Ph+ ALL patient that would be deemed transplant eligible. Summary Acute lymphoblastic leukaemia (ALL) in 20%–30% of
Naranie Shanmuganathan, Andrew Grigg
wiley   +1 more source

CPX-351 and the Frontier of Nanoparticle-Based Therapeutics in Acute Myeloid Leukemia. [PDF]

Int J Mol Sci
Konstantinidis I, Tsokkou S, Keramas A, Gavriilaki E, Delis G, Papamitsou T.   +5 more
europepmc   +1 more source